Breaking News Bar

Business News and Information

Aerie thinks long term, wants to bring in more drugs

Standing in a small lab space off Kit Creek Road, Casey Kopczynski has big plans. Kopczynski, the chief scientific officer with Aerie Pharmaceuticals (Nasdaq: AERI), and his colleagues are working to bring a glaucoma treatment to market and capture 40 percent of a market they estimate at $5 billion annually...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear